Characterisation of trials published in medical journals to determine whether there are specific characteristics of trials that are designed primarily for the purpose of marketing and, if identified, what the prevalence and distribution of such trials is 2011
Mistakes in research are inevitable, and publishing corrections is vital for the integrity of the literature. These errata rarely require a retraction, and are therefore considered a lesser concern. This perception might be wrong, however, because the actual prevalence, nature and impact of errors across disciplines are unknown. Indeed, while several large studies have looked at retractions, existing studies on errata are small, limited in scope and rather different in methods and aims.
There is growing interest in sharing of research data, as data sharing is expected to accelerate research and increase accountability. Sharing of data underlying published research is an increasingly important consideration for peer-reviewed journals, and some journals require researchers to state their data sharing policy in published articles. However, the field of clinical trials has been slow to adopt a culture of data transparency.
This project led by Drs Zubin Master (PI) and Bryn Williams-Jones (co-Investigator) aims to better understand the norms, values, practices, and knowledge surrounding research integrity that contribute to authorship assignment and ranking in multi/interdisciplinary research groups, using public health researchers as a case study.